[110] By immunostaining MIF in specimens from 50 HNSCC patients treated with chemoradiotherapy, Suzuki et al. demonstrated that MIF-negative was association with poor prognoses. This evidence concerns the gene MIF and head and neck squamous cell carcinoma.